These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 32862049)

  • 1. Molecular mechanisms employed by enteric bacterial pathogens to antagonise host innate immunity.
    Gan J; Giogha C; Hartland EL
    Curr Opin Microbiol; 2021 Feb; 59():58-64. PubMed ID: 32862049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of the Inflammasome Signaling Pathway by Enteropathogenic and Enterohemorrhagic Escherichia coli.
    Yen H; Karino M; Tobe T
    Front Cell Infect Microbiol; 2016; 6():89. PubMed ID: 27617233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host Cell Targeting by Enteropathogenic Bacteria T3SS Effectors.
    Pinaud L; Sansonetti PJ; Phalipon A
    Trends Microbiol; 2018 Apr; 26(4):266-283. PubMed ID: 29477730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salmonella, E. coli, and Citrobacter Type III Secretion System Effector Proteins that Alter Host Innate Immunity.
    El Qaidi S; Wu M; Zhu C; Hardwidge PR
    Adv Exp Med Biol; 2019; 1111():205-218. PubMed ID: 30411307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NleB/SseK effectors from
    El Qaidi S; Chen K; Halim A; Siukstaite L; Rueter C; Hurtado-Guerrero R; Clausen H; Hardwidge PR
    J Biol Chem; 2017 Jul; 292(27):11423-11430. PubMed ID: 28522607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bringing down the host: enteropathogenic and enterohaemorrhagic Escherichia coli effector-mediated subversion of host innate immune pathways.
    Santos AS; Finlay BB
    Cell Microbiol; 2015 Mar; 17(3):318-32. PubMed ID: 25588886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shigella IpaH Family Effectors as a Versatile Model for Studying Pathogenic Bacteria.
    Ashida H; Sasakawa C
    Front Cell Infect Microbiol; 2015; 5():100. PubMed ID: 26779450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of host signaling in the inflammatory response by enteropathogenic Escherichia coli virulence proteins.
    Zhuang X; Chen Z; He C; Wang L; Zhou R; Yan D; Ge B
    Cell Mol Immunol; 2017 Mar; 14(3):237-244. PubMed ID: 27796284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The
    Schubert KA; Xu Y; Shao F; Auerbuch V
    Annu Rev Microbiol; 2020 Sep; 74():221-245. PubMed ID: 32660389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enteropathogenic Escherichia coli Uses NleA to Inhibit NLRP3 Inflammasome Activation.
    Yen H; Sugimoto N; Tobe T
    PLoS Pathog; 2015 Sep; 11(9):e1005121. PubMed ID: 26332984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EspFu-Mediated Actin Assembly Enhances Enteropathogenic
    Martins FH; Kumar A; Abe CM; Carvalho E; Nishiyama-Jr M; Xing C; Sperandio V; Elias WP
    mBio; 2020 Apr; 11(2):. PubMed ID: 32291304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cooperative Immune Suppression by Escherichia coli and Shigella Effector Proteins.
    de Jong MF; Alto NM
    Infect Immun; 2018 Apr; 86(4):. PubMed ID: 29339461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vying for the control of inflammasomes: The cytosolic frontier of enteric bacterial pathogen-host interactions.
    Sanchez-Garrido J; Slater SL; Clements A; Shenoy AR; Frankel G
    Cell Microbiol; 2020 Apr; 22(4):e13184. PubMed ID: 32185892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subversion of trafficking, apoptosis, and innate immunity by type III secretion system effectors.
    Raymond B; Young JC; Pallett M; Endres RG; Clements A; Frankel G
    Trends Microbiol; 2013 Aug; 21(8):430-41. PubMed ID: 23870533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indole Signaling at the Host-Microbiota-Pathogen Interface.
    Kumar A; Sperandio V
    mBio; 2019 Jun; 10(3):. PubMed ID: 31164470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attaching and effacing pathogens: the effector ABC of immune subversion.
    Riebisch AK; Mühlen S
    Future Microbiol; 2020 Jul; 15():945-958. PubMed ID: 32716209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivery of dangerous goods: type III secretion in enteric pathogens.
    Zaharik ML; Gruenheid S; Perrin AJ; Finlay BB
    Int J Med Microbiol; 2002 Mar; 291(8):593-603. PubMed ID: 12008913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of Host Cell Processes by T3SS Effectors.
    Shenoy AR; Furniss RCD; Goddard PJ; Clements A
    Curr Top Microbiol Immunol; 2018; 416():73-115. PubMed ID: 30178263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting of immune signalling networks by bacterial pathogens.
    Brodsky IE; Medzhitov R
    Nat Cell Biol; 2009 May; 11(5):521-6. PubMed ID: 19404331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Programmed Cell Death in the Evolutionary Race against Bacterial Virulence Factors.
    Lacey CA; Miao EA
    Cold Spring Harb Perspect Biol; 2020 Feb; 12(2):. PubMed ID: 31501197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.